Primary cutaneous aspergillosis

Primary cutaneous aspergillosis
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Skin lesions, nodules, ulcers
Complications	Systemic infection
Onset	Rapid
Duration	Variable
Types	N/A
Causes	Aspergillus species
Risks	Immunocompromised state
Diagnosis	Biopsy, culture
Differential diagnosis	N/A
Prevention	N/A
Treatment	Antifungal medications
Medication	N/A
Prognosis	Variable
Frequency	N/A
Deaths	N/A

Primary cutaneous aspergillosis is a rare fungal infection of the skin caused by the Aspergillus species. It typically occurs in immunocompromised individuals, such as those undergoing chemotherapy, organ transplantation, or with HIV/AIDS.

Presentation

The condition presents with skin lesions that may appear as nodules, ulcers, or plaques. These lesions can be painful and may progress rapidly, especially in individuals with weakened immune systems.

Causes

Primary cutaneous aspergillosis is caused by direct inoculation of Aspergillus spores into the skin. This can occur through trauma, surgery, or the use of intravenous catheters. The most common species involved is Aspergillus fumigatus.

Diagnosis

Diagnosis is typically made through a combination of biopsy and culture of the affected skin. Histopathology may reveal characteristic fungal hyphae, and culture can identify the specific Aspergillus species.

Treatment

Treatment involves the use of antifungal medications, such as voriconazole or amphotericin B. In some cases, surgical debridement of the infected tissue may be necessary.

Prognosis

The prognosis of primary cutaneous aspergillosis varies depending on the patient's immune status and the timeliness of treatment. Early diagnosis and appropriate antifungal therapy can improve outcomes.

See also

• Aspergillosis
• Fungal skin infections
• Immunocompromised host

References

<references />